Clinical Diagnoses of ASD Mostly Consistent With, Without ADOS
FRIDAY, Oct. 21, 2022 (HealthDay News) -- Clinical diagnoses of autism spectrum disorder (ASD) with and without the reference standard Autism Diagnostic Observation Schedule (ADOS) are consistent in 90.0 percent of cases, according to a study published online Oct. 17 in JAMA Pediatrics.
William Barbaresi, M.D., from Boston Children's Hospital, and colleagues examined consistency between clinical diagnosis and diagnosis incorporating the ADOS in a prospective study conducted between May 2019 and February 2020. Developmental-behavioral pediatricians (DBPs) made a diagnosis based on clinical assessment; the ADOS was administered and then a DBP made a second diagnosis (index diagnosis and reference standard diagnosis). A total of 349 children completed the study.
The researchers found that index diagnoses and reference standard diagnoses were consistent for 314 children (90 percent) and changed for 35 children. The most sensitive and specific predictor of diagnostic consistency was clinician diagnostic certainty (area under curve, 0.860). No child or clinician factors improved prediction of diagnostic consistency based solely on clinician diagnostic certainty at the time of index diagnosis in a multilevel logistic regression.
"ASD diagnostic assessments that do not include the ADOS are less time consuming and costly, potentially leading to more streamlined assessments that could improve access to timely diagnosis by more children," the authors write. "Additionally, this study suggests that results from the ADOS should not be required by insurers, early intervention programs, or schools for children to access intervention and treatment for ASD."
Abstract/Full Text (subscription or payment may be required)
Related Posts
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important...
Health Highlights: Dec. 17, 2021
Masking up again? Here's what works best. New research finds that when it comes...
What You Need to Know About the Infant Formula Recall
WEDNESDAY, March 2, 2022 (HealthDay News) -- If you're a parent using Similac,...
Pfizer afirma que su dosis de refuerzo mejora la respuesta inmunitaria en los niños de 5 a 11 años
JUEVES, 14 de abril de 2022 (HealthDay News) -- Pfizer Inc. afirmó el jueves que...